title: Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages.
abstract: Tumor necrosis factor alpha (TNF-alpha) plays an important role in the host immune response to infection with the intracellular pathogen Mycobacterium tuberculosis. It is essential for the formation of protective tuberculous granulomas and regulates the expression of other cytokines which contribute to a protective immune response. Interleukin-12 (IL-12) is known to promote a Th1 response, which is essential for antimycobacterial resistance. Recombinant guinea pig TNF-alpha (rgpTNF-alpha) protein (17 kDa) was purified, and its bioactivity was confirmed by its cytotoxicity for L929 fibroblasts. High titers of polyclonal anti-gpTNF-alpha antibody were obtained by immunization of rabbits. Resident alveolar and peritoneal macrophages were isolated from guinea pigs and infected with either the H37Ra or H37Rv strain of M. tuberculosis. The mRNA levels for TNF-alpha and IL-12 p40 were measured using real-time PCR. IL-12 p40 mRNA was up-regulated in a dose-dependent manner by rgpTNF-alpha alone. In infected macrophages, a lower dose of rgpTNF-alpha intensified the mRNA levels of TNF-alpha and IL-12 p40. However, higher doses of rgpTNF-alpha suppressed TNF-alpha and IL-12 p40 mRNA. The antimycobacterial activity of macrophages was assessed by metabolic labeling of M. tuberculosis with [3H]uracil. Resident alveolar and peritoneal macrophages treated with anti-gpTNF-alpha antibody to block endogenous TNF-alpha exhibited increased intracellular mycobacterial growth. These data suggest that the dose of TNF-alpha is crucial to the stimulation of optimal expression of protective cytokines and that TNF-alpha contributes to the control of mycobacterial replication to promote host resistance against M. tuberculosis.
authors.affiliation: Department of Medical Microbiology and Immunology, The Texas A&M University System Health Science Center, 407 Reynolds Medical Building, College Station, TX 77843-1114, USA. HScho@medicine.tamu.edu
authors.forename: Hyosun
authors.initials: H
authors.lastname: Cho
authors.forename: Todd M
authors.initials: TM
authors.lastname: Lasco
authors.forename: Shannon Sedberry
authors.initials: SS
authors.lastname: Allen
authors.forename: Teizo
authors.initials: T
authors.lastname: Yoshimura
authors.forename: David N
authors.initials: DN
authors.lastname: McMurray
mesh_terms: D000818:Animals; D006168:Guinea Pigs; D018664:Interleukin-12 / Q000378:metabolism*; D053762:Interleukin-12 Subunit p40; D008262:Macrophage Activation; D016676:Macrophages, Alveolar / Q000276:immunology / Q000382:microbiology*; D017737:Macrophages, Peritoneal / Q000276:immunology / Q000382:microbiology*; D009169:Mycobacterium tuberculosis / Q000254:growth & development* / Q000472:pathogenicity; D021122:Protein Subunits / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D011817:Rabbits; D011994:Recombinant Proteins / Q000276:immunology*; D014376:Tuberculosis / Q000276:immunology / Q000382:microbiology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology* / Q000378:metabolism; D015854:Up-Regulation
chemical_list: D053762:Interleukin-12 Subunit p40; D021122:Protein Subunits; D012333:RNA, Messenger; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D018664:Interleukin-12
references.citation: Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8093-8
references.pmid: 9223320
references.citation: J Exp Med. 1997 Jul 7;186(1):39-45
references.pmid: 9206995
references.citation: Am J Physiol. 1997 Sep;273(3 Pt 1):L524-30
references.pmid: 9316485
references.citation: Infect Immun. 1997 Dec;65(12):5149-56
references.pmid: 9393809
references.citation: Infect Immun. 1998 Mar;66(3):927-31
references.pmid: 9488377
references.citation: Infect Immun. 1998 Mar;66(3):1190-9
references.pmid: 9488413
references.citation: Pathobiology. 1998;66(1):24-32
references.pmid: 9577963
references.citation: Infect Immun. 1998 Jun;66(6):2951-9
references.pmid: 9596772
references.citation: J Immunol. 1998 Aug 1;161(3):1447-53
references.pmid: 9686610
references.citation: J Infect Dis. 1998 Aug;178(2):580-4
references.pmid: 9697749
references.citation: Rheum Dis Clin North Am. 1998 Aug;24(3):593-614
references.pmid: 9710889
references.citation: Tuber Lung Dis. 1997;78(3-4):145-58
references.pmid: 9713647
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13806-11
references.pmid: 9811882
references.citation: J Immunol. 1999 Feb 15;162(4):2321-5
references.pmid: 9973510
references.citation: Infect Immun. 1999 Sep;67(9):4531-8
references.pmid: 10456896
references.citation: J Immunol. 1999 Oct 1;163(7):3653-61
references.pmid: 10490959
references.citation: Infect Immun. 1999 Oct;67(10):5473-6
references.pmid: 10496932
references.citation: J Immunol. 2000 Feb 15;164(4):1722-9
references.pmid: 10657616
references.citation: J Leukoc Biol. 2000 Apr;67(4):545-52
references.pmid: 10770288
references.citation: J Immunol. 2000 Jun 1;164(11):5564-74
references.pmid: 10820230
references.citation: Eur J Immunol. 2000 Jun;30(6):1562-7
references.pmid: 10898491
references.citation: Infect Immun. 2000 Dec;68(12):6954-61
references.pmid: 11083819
references.citation: Exp Lung Res. 2001 Jan - Feb;27(1):65-76
references.pmid: 11202064
references.citation: Cell. 2001 Feb 23;104(4):477-85
references.pmid: 11239406
references.citation: Trends Mol Med. 2001 Mar;7(3):135-7
references.pmid: 11286786
references.citation: Eur Respir J. 2001 May;17(5):1049-51
references.pmid: 11488308
references.citation: J Immunol. 2002 Feb 1;168(3):1328-37
references.pmid: 11801673
references.citation: Nat Rev Immunol. 2001 Oct;1(1):20-30
references.pmid: 11905811
references.citation: Infect Immun. 2002 Oct;70(10):5471-8
references.pmid: 12228272
references.citation: Infect Immun. 2003 Jan;71(1):354-64
references.pmid: 12496185
references.citation: Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):193-209
references.pmid: 12787559
references.citation: J Immunol. 2003 Sep 15;171(6):3110-8
references.pmid: 12960337
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12420-5
references.pmid: 14557547
references.citation: Infect Immun. 2003 Dec;71(12):7035-42
references.pmid: 14638793
references.citation: Infect Immun. 2004 May;72(5):2976-88
references.pmid: 15102810
references.citation: J Bacteriol. 1967 Oct;94(4):832-5
references.pmid: 4964472
references.citation: Cell. 1989 Mar 10;56(5):731-40
references.pmid: 2647299
references.citation: Infect Immun. 1990 Aug;58(8):2675-7
references.pmid: 2115027
references.citation: J Immunol. 1990 Aug 1;145(3):940-4
references.pmid: 2115549
references.citation: Immunology. 1991 Sep;74(1):60-7
references.pmid: 1937574
references.citation: J Leukoc Biol. 1991 Nov;50(5):495-501
references.pmid: 1748843
references.citation: J Immunol Methods. 1993 Jan 4;157(1-2):91-9
references.pmid: 8423377
references.citation: J Immunol. 1993 Jul 1;151(1):518-25
references.pmid: 8100846
references.citation: J Exp Med. 1993 Dec 1;178(6):2249-54
references.pmid: 7504064
references.citation: Blood. 1994 Apr 1;83(7):1847-55
references.pmid: 7908232
references.citation: J Exp Med. 1995 May 1;181(5):1615-21
references.pmid: 7722441
references.citation: Immunity. 1995 Jun;2(6):561-72
references.pmid: 7540941
references.citation: Cell Immunol. 1995 Jul;163(2):260-7
references.pmid: 7606797
references.citation: J Clin Immunol. 1996 May;16(3):144-50
references.pmid: 8734357
references.citation: Annu Rev Immunol. 1997;15:749-95
references.pmid: 9143706
references.citation: Bone Marrow Transplant. 1997 Sep;20(6):511-5
references.pmid: 9313887